LOS ANGELES (Reuters) - The risk of miscarriage after undergoing chorionic villus sampling, or CVS, to detect birth defects is lower than previously thought and essentially carries the same risk than the more commonly used amniocentesis, according to new research.>>> Discuss This Story
